And then there were three

Another consumer division spinoff on the way, this time by Sanofi Pharmaceutical giant Sanofi has portrayed how it imagines spinning off its consumer division and turning the parent, in the words of CEO Paul Hudson, into a “pure play biopharma company”. The announcement last Friday made more concrete what has been speculated upon since Bloomberg